Q1 2024 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2024-05-15 · accession 0001172661-24-002421
$1.08B
Reported value
80
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 88033G407 | THC | TENET HEALTHCARE CORP | $44.7M | 4.15% | 425,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $41.1M | 3.81% | 600,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $36.9M | 3.43% | 450,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $35.3M | 3.27% | 1,300,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $31.5M | 2.93% | 450,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $31.0M | 2.88% | 235,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $28.9M | 2.68% | 350,000 | Common | SOLE |
| 931427108 | WFC | WALGREENS BOOTS ALLIANCE INC | $28.2M | 2.62% | 1,300,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $25.9M | 2.41% | 50,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $24.6M | 2.28% | 300,000 | PUT | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $24.6M | 2.28% | 135,000 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $22.8M | 2.12% | 125,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $21.8M | 2.02% | 225,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $21.4M | 1.99% | 590,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $21.1M | 1.95% | 975,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $20.8M | 1.93% | 60,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $20.7M | 1.92% | 150,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $20.7M | 1.92% | 220,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $20.0M | 1.85% | 50,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $19.9M | 1.85% | 210,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $17.7M | 1.65% | 255,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $17.6M | 1.63% | 65,000 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $16.4M | 1.52% | 17,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $16.0M | 1.49% | 760,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $15.6M | 1.45% | 70,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $15.5M | 1.44% | 360,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $15.2M | 1.41% | 325,000 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $15.1M | 1.40% | 45,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $15.0M | 1.39% | 220,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $14.5M | 1.35% | 40,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $14.2M | 1.32% | 80,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $13.9M | 1.29% | 100,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $13.6M | 1.26% | 500,000 | CALL | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $13.5M | 1.26% | 420,000 | Common | SOLE |
| 82489T104 | SWAVUSD | SHOCKWAVE MED INC | $13.0M | 1.21% | 40,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $12.8M | 1.19% | 500,000 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $12.1M | 1.13% | 50,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $11.8M | 1.09% | 2,250,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $11.2M | 1.04% | 110,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $11.1M | 1.03% | 220,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $10.4M | 0.96% | 150,000 | CALL | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $10.0M | 0.93% | 200,000 | CALL | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $9.8M | 0.91% | 980,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $9.6M | 0.89% | 200,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $9.3M | 0.87% | 12,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $9.2M | 0.85% | 50,000 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $9.1M | 0.85% | 230,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $9.0M | 0.83% | 550,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $8.8M | 0.82% | 150,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $8.7M | 0.80% | 125,000 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $8.2M | 0.76% | 250,000 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $8.0M | 0.74% | 225,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $8.0M | 0.74% | 250,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $7.5M | 0.69% | 50,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $7.4M | 0.69% | 500,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $7.4M | 0.69% | 165,000 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $7.4M | 0.68% | 500,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $7.3M | 0.67% | 425,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $7.1M | 0.66% | 33,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $6.8M | 0.63% | 250,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $6.3M | 0.59% | 600,000 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $6.3M | 0.58% | 40,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $6.0M | 0.56% | 725,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $5.8M | 0.54% | 325,000 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $5.3M | 0.49% | 50,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $4.9M | 0.46% | 15,000 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $4.6M | 0.42% | 50,000 | Common | SOLE |
| 50540R409 | LSI | LABORATORY CORP AMER HLDGS | $4.4M | 0.41% | 20,000 | Common | SOLE |
| 00846U101 | A | AGILENT TECHNOLOGIES INC | $4.4M | 0.41% | 30,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $3.8M | 0.35% | 100,000 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $3.7M | 0.35% | 200,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $3.5M | 0.32% | 300,000 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $3.3M | 0.31% | 450,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $3.2M | 0.30% | 500,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.1M | 0.29% | 950,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $3.1M | 0.29% | 150,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $2.7M | 0.25% | 40,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.6M | 0.25% | 40,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $2.4M | 0.22% | 30,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $1.5M | 0.14% | 200,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.